SAPHTX
Saphtx develops protein-based therapeutic strategies for a wide range of diseases. The company was founded in 2018 and is headquartered in Newark, New Jersey.
SAPHTX
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Newark, Delaware, United States
Country:
United States
Website Url:
http://www.saphtx.com
Status:
Active
Contact:
973-943-8314
Email Addresses:
[email protected]
Total Funding:
255.93 K USD
Similar Organizations
GlycoMira
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.
Iria Pharma
Iria Pharma develops cancer targeting and drug delivery technology to provide a platform for targeted cancer therapeutics.
Merand Pharmaceuticals
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Peptineo
Peptineo provides Nano-based therapeutics for existing and emerging diseases.
Si Legend
Si Legend develops a therapeutic drug for intractable retinal disease.
Syntimmune
Syntimmune develops differentiated drug candidates in a wide range of autoimmune diseases.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Saphtx
